MEIP DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds MEI Pharma, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 9, 2020Business Wire • 10/09/20
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/09/20
MEIP Final Deadline Notice: Rosen, A Longstanding And Top Ranked Law Firm, Reminds MEI Pharma, Inc. Investors of Important Friday Deadline in Securities Class Action - MEIPNewsfile Corp • 10/08/20
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/08/20
FRIDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/07/20
FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/06/20
FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/05/20
ROSEN, A TRUSTED AND TOP RANKED LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIPNewsfile Corp • 10/02/20
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/02/20
Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's LymphomaPRNewsWire • 10/02/20
ROSEN, A LEADING LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIPPRNewsWire • 09/29/20
MEI Pharma Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MEI Pharma, Inc. To Contact The FirmNewsfile Corp • 09/25/20
Rosen, A Trusted and Leading Law Firm, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIPNewsfile Corp • 09/23/20
Rosen, Trusted Global Investor Counsel, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIPNewsfile Corp • 09/18/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - MEIPPRNewsWire • 09/15/20
ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIPPRNewsWire • 09/14/20
ROSEN, A LEADING LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MEIPNewsfile Corp • 09/12/20
ROSEN, A TOP RANKED LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action – MEIPBusiness Wire • 09/10/20
MEI Pharma, Inc. (MEIP) CEO Dan Gold on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 09/10/20
Rosen, Leading Trial Attorneys, Announces Filing of Securities Class Action Lawsuit Against MEI Pharma, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - MEIPNewsfile Corp • 09/05/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - MEIPPRNewsWire • 08/28/20
ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds MEI Pharma, Inc. Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – MEIPBusiness Wire • 08/26/20
